Tevogen Bio Holdings Inc. financial data

Symbol
TVGN, TVGNW on Nasdaq
Location
15 Independence Boulevard, Suite 410, Warren, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Semper Paratus Acquisition Corp (to 2/15/2024)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 6.52 % -87.7%
Debt-to-equity -110 % -257%
Return On Equity -176 % -281%
Return On Assets 565 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 166M shares
Common Stock, Shares, Outstanding 169M shares
Entity Public Float 25.5M USD -92.6%
Common Stock, Value, Issued 16.9K USD
Weighted Average Number of Shares Outstanding, Basic 154M shares +28.5%
Weighted Average Number of Shares Outstanding, Diluted 154M shares +28.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.12M USD +300%
General and Administrative Expense 13.3M USD +424%
Costs and Expenses 29.5M USD +884%
Operating Income (Loss) -8.6M USD -294%
Nonoperating Income (Expense) 2.21M USD -58.8%
Net Income (Loss) Attributable to Parent 54.5M USD +56.4%
Earnings Per Share, Basic -0.04 USD/shares +77.8%
Earnings Per Share, Diluted -0.04 USD/shares +77.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25M USD +17377%
Assets, Current 2.45M USD +250%
Property, Plant and Equipment, Net 378K USD
Operating Lease, Right-of-Use Asset 353K USD
Other Assets, Noncurrent 133K USD
Assets 3.31M USD -87.4%
Accounts Payable, Current 6.67M USD
Accrued Liabilities, Current 1.78M USD
Liabilities, Current 10.6M USD +598%
Operating Lease, Liability, Noncurrent 96.8K USD
Liabilities 10.9M USD -32.7%
Retained Earnings (Accumulated Deficit) -98.1M USD -531%
Stockholders' Equity Attributable to Parent -7.63M USD +91.2%
Liabilities and Equity 3.31M USD -87.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.16M USD +0.61%
Net Cash Provided by (Used in) Financing Activities 2.43M USD -2.83%
Net Cash Provided by (Used in) Investing Activities -133K USD
Common Stock, Shares Authorized 800M shares
Common Stock, Shares, Issued 169M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.14M USD -67.2%
Depreciation 40.6K USD +2.06%
Payments to Acquire Property, Plant, and Equipment 133K USD
Operating Lease, Liability, Current 269K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares +1900%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 87.6M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4.14M USD
Interest Expense 156K USD -46.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%